Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C10H13ClN2 |
| Molecular Weight | 196.677 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
ClC1=CC=CC(=C1)N2CCNCC2
InChI
InChIKey=VHFVKMTVMIZMIK-UHFFFAOYSA-N
InChI=1S/C10H13ClN2/c11-9-2-1-3-10(8-9)13-6-4-12-5-7-13/h1-3,8,12H,4-7H2
m-Chlorophenylpiperazine (meta-chlorophenylpiperazine or mCPP) is a psychoactive substance, which is illegal in many countries but can be found on the black market. It induces endocrine, neurological and psychiatric effects. mCPP is a partial agonist at the 5-HT2C receptor but antagonized the 5-HT2B and 5-HT3 receptors. mCPP is also an active metabolite of the drug trazodone, which is used as an effective antidepressant drug with a broad therapeutic spectrum, including anxiolytic efficacy. It is known, that mCPP induces migraine attacks and that the decrease of food intake induced by the mCPP depends on its ability to act as a serotonin agonist is a brain.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: P28335 Gene ID: 3358.0 Gene Symbol: HTR2C Target Organism: Homo sapiens (Human) |
|||
Target ID: P41595 Gene ID: 3357.0 Gene Symbol: HTR2B Target Organism: Homo sapiens (Human) |
|||
Target ID: P08908 Gene ID: 3350.0 Gene Symbol: HTR1A Target Organism: Homo sapiens (Human) |
|||
Target ID: CHEMBL2094132 |
61.4 nM [IC50] | ||
Target ID: CHEMBL224 |
6.65 null [pEC50] | ||
Target ID: CHEMBL225 |
7.09 null [pEC50] | ||
Target ID: CHEMBL1833 |
7.2 null [pEC50] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
PubMed
| Title | Date | PubMed |
|---|---|---|
| The effects of serotonin agonists on the hypothalamic regulation of sexual receptivity in Syrian hamsters. | 2002 Aug |
|
| Metachlorophenylpiperazine (m-CPP) induced intracavernous pressure responses in anaesthetized rats. | 2002 Aug |
|
| Relationship between plasma concentrations of trazodone and its active metabolite, m-chlorophenylpiperazine, and its clinical effect in depressed patients. | 2002 Aug |
|
| 5-HT(2C) receptor activation by m-chlorophenylpiperazine detected in humans with fMRI. | 2002 Aug 27 |
|
| Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism? | 2002 Dec |
|
| Antidepressants reduce phosphoinositide-specific phospholipase C (PI-PLC) activity and the mRNA and protein expression of selective PLC beta 1 isozyme in rat brain. | 2002 Dec |
|
| Serotonergic dysregulation in bipolar disorders: a literature review of serotonergic challenge studies. | 2002 Dec |
|
| Cognitive performance of MDMA-treated rhesus monkeys: sensitivity to serotonergic challenge. | 2002 Dec |
|
| Synthesis and pharmacological evaluation of new arylpiperazines. 3-[4-[4-(3-chlorophenyl)-1-piperazinyl]butyl]-quinazolidin-4-one - a dual serotonin 5-HT(1A)/5-HT(2A) receptor ligand with an anxiolytic-like activity. | 2002 Dec |
|
| Neuroendocrine response to meta-chlorophenylpiperazine and ipsapirone in relation to anxiety and aggression. | 2002 Dec 15 |
|
| Therapeutic and adverse actions of serotonin transporter substrates. | 2002 Jul |
|
| Blunted prefrontal cortical 18fluorodeoxyglucose positron emission tomography response to meta-chlorophenylpiperazine in impulsive aggression. | 2002 Jul |
|
| Central administration of mCPP, a serotonin 5-HT(2B/2C) agonist, decreases water intake in rats. | 2002 Jul |
|
| Ritanserin antagonism of m-chlorophenylpiperazine effects in neuroleptic-free schizophrenics patients: support for serotonin-2 receptor modulation of schizophrenia symptoms. | 2002 Jun |
|
| Saccadic peak velocity and EEG as end-points for a serotonergic challenge test. | 2002 Mar |
|
| Antinociceptive role of 5-HT1A receptors in rat spinal cord. | 2002 May |
|
| Ethopharmacological analysis of the unstable elevated exposed plus maze, a novel model of extreme anxiety: predictive validity and sensitivity to anxiogenic agents. | 2002 May |
|
| Allelic variants of the serotonin(2C) receptor and neuroendocrinological responses to the serotonin(2C) receptor agonist m-chlorophenylpiperazine in healthy male volunteers. | 2002 Nov |
|
| In vitro identification of metabolic pathways and cytochrome P450 enzymes involved in the metabolism of etoperidone. | 2002 Nov |
|
| The effects of gender and gonadal steroids on the neuroendocrine and temperature response to m-chlorophenylpiperazine in leuprolide-induced hypogonadism in women and men. | 2002 Nov |
|
| 5-HT2C receptor mediation of unconditioned escape behaviour in the unstable elevated exposed plus maze. | 2002 Nov |
|
| 2'-NH(2)-MPTP [1-methyl-4-(2'-aminophenyl)-1,2,3,6-tetrahydropyridine] depletes serotonin and norepinephrine in rats: a comparison with 2'-CH(3)-MPTP [1-methyl-4-(2'-methylphenyl)-1,2,3,6-tetrahydropyridine]. | 2002 Nov |
|
| Sleep-wake effects of meta-chlorophenyl piperazine and mianserin in the behaviorally depressed rat. | 2002 Nov 22 |
|
| mCPP-induced hypophagia in rats is unaffected by the profile of dietary unsaturated fatty acids. | 2002 Oct |
|
| Effects of GABA(A) compounds on mCPP drug discrimination in rats. | 2002 Oct 18 |
|
| p-Methylthioamphetamine and 1-(m-chlorophenyl)piperazine, two non-neurotoxic 5-HT releasers in vivo, differ from neurotoxic amphetamine derivatives in their mode of action at 5-HT nerve endings in vitro. | 2002 Sep |
|
| 5-HT2C receptor agonists as potential drugs for the treatment of obesity. | 2003 |
|
| Serotonin induces tonic firing in layer V pyramidal neurons of rat prefrontal cortex during postnatal development. | 2003 Apr 15 |
|
| Effects of m-CPP in altering neuronal function: blocking depolarization in invertebrate motor and sensory neurons but exciting rat dorsal horn neurons. | 2003 Apr 18 |
|
| MDMA exposure alters cognitive and electrophysiological sensitivity to rapid tryptophan depletion in rhesus monkeys. | 2003 Aug |
|
| Regulation of septo-hippocampal activity by 5-hydroxytryptamine(2C) receptors. | 2003 Aug |
|
| Discriminative stimulus effects of m-chlorophenylpiperazine as a model of the role of serotonin receptors in anxiety. | 2003 Aug 1 |
|
| Central 5-HT2B/2C and 5-HT3 receptor stimulation decreases salt intake in sodium-depleted rats. | 2003 Aug 15 |
|
| Effect of repeated administration of dexfenfluramine on feeding and brain Fos in mice. | 2003 Feb |
|
| Differential regulation of somatodendritic and nerve terminal dopamine release by serotonergic innervation of substantia nigra. | 2003 Feb |
|
| Induction of c-Fos expression in specific areas of the fear circuitry in rat forebrain by anxiogenic drugs. | 2003 Feb 15 |
|
| 5-HT1B receptor knockout mice show a compensatory reduction in 5-HT2C receptor function. | 2003 Jan |
|
| Pharmacological characterization of 5-HT(1B) receptor-mediated inhibition of local excitatory synaptic transmission in the CA1 region of rat hippocampus. | 2003 Jan |
|
| Central serotonergic effects of m-chlorophenylpiperazine (mCPP) among normal control adolescents. | 2003 Jan |
|
| Neuroendocrine response to the serotonin agonist M-chlorophenylpiperazine in women with menstrual status migrainosus. | 2003 Jul |
|
| Serotonin in the dorsal periaqueductal gray modulates inhibitory avoidance and one-way escape behaviors in the elevated T-maze. | 2003 Jul 25 |
|
| Screening for and validated quantification of amphetamines and of amphetamine- and piperazine-derived designer drugs in human blood plasma by gas chromatography/mass spectrometry. | 2003 Jun |
|
| Effects of single and repeated electroconvulsive shock on the social and agonistic behaviour of resident rats. | 2003 Jun |
|
| m-CPP-induced self-grooming is mediated by 5-HT2C receptors. | 2003 Jun 16 |
|
| The glycine transporter-1 inhibitors NFPS and Org 24461: a pharmacological study. | 2003 Mar |
|
| Reduced social interaction following 3,4-methylenedioxymethamphetamine is not associated with enhanced 5-HT 2C receptor responsivity. | 2003 Mar |
|
| Neurogenic dural protein extravasation induced by meta-chlorophenylpiperazine (mCPP) involves nitric oxide and 5-HT2B receptor activation. | 2003 Mar |
|
| Experimental anxiety and antiepileptics: the effects of valproate and vigabatrin in the mirrored chamber test. | 2003 May |
|
| Agonist actions of dihydroergotamine at 5-HT2B and 5-HT2C receptors and their possible relevance to antimigraine efficacy. | 2003 Sep |
|
| A PET study after treatment with an anxiety-provoking agent, m-chlorophenyl-piperazine, in conscious rhesus monkeys. | 2003 Sep |
Sample Use Guides
Eight female and six male healthy volunteers were included in a randomized, double-blind, double-dummy, three-way crossover design of single-dose intravenous (0.1 mg/kg), oral (0.5 mg/kg), and placebo treatment, with 24-hour follow-up. meta-Chlorophenylpiperazine (mCPP) showed a large variability in clearance (11-92 mL/hr) and bioavailability (14-108%).
Route of Administration:
Other
meta-Chlorophenylpiperazine (mCPP) showed relatively high affinity at brain 5HT3 receptors (IC50 = 61.4 nM), it did not activate the von Bezold-Jarisch reflex; instead, mCPP potently antagonized serotonin-induced bradycardia. Thus, mCPP acts as an antagonist at 5HT3 receptors in the periphery
| Name | Type | Language | ||
|---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Brand Name | English | ||
|
Systematic Name | English | ||
|
Code | English | ||
|
Systematic Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
WIKIPEDIA |
Designer-drugs-3-Chlorophenylpiperazine
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6640-24-0
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
229-654-7
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
100000139315
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
10588
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
SUB87155
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
DTXSID9045138
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
REY0CNO998
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
META-CHLOROPHENYLPIPERAZINE
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
1355
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
DB12110
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY | |||
|
49307
Created by
admin on Fri Dec 15 15:26:28 GMT 2023 , Edited by admin on Fri Dec 15 15:26:28 GMT 2023
|
PRIMARY |
ACTIVE MOIETY
METABOLITE (PARENT)
PARENT (METABOLITE ACTIVE)
PARENT (METABOLITE ACTIVE)
PARENT (METABOLITE ACTIVE)
PARENT (METABOLITE ACTIVE)
SALT/SOLVATE (PARENT)
SALT/SOLVATE (PARENT)
